当前位置: X-MOL首页全球导师 国内导师 › 刘振球

个人简介

工作经历 2010.9 - 2015.6,安徽医科大学,预防医学专业,本科 2015.9 - 2018.6,复旦大学,流行病与卫生统计学专业,硕士 2018.9 - 2021.6,复旦大学,遗传学专业,博士 2021.6 - 2023.12,复旦大学人类表型组研究院,博士后 2023.12 至今,复旦大学人类表型组研究院,青年研究员 获奖情况 2018、2021年,上海市优秀毕业生 2020年,复旦大学学术之星 2021年,第六届“博新计划” 2021年,上海市“超级博士后”

研究领域

慢性肝脏疾病(脂肪肝、病毒性肝炎、肝癌)分子/遗传流行病学

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

Liu Z#, Jiang Y#, Yuan H, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention. J Hepatol. 2019; 70(4): 674–683. Liu Z#, Mao X#, Wu J#, et al. World-wide prevalence of substitutions in HCV genome associated with resistance to direct-acting antiviral agents. Clin Gastroenterol Hepatol. 2021; 19 (9): 1906-1914. Liu Z#, Xu K#, Jiang Y, et al. Global trend of aetiology-based primary liver cancer incidence from 1990 to 2030: a modelling study. Int J Epidemiol. 2021;50(1): 128-142. Liu Z#, Suo C#, Shi O, et al. The health impact of MAFLD, a novel disease cluster of NAFLD, is amplified by the integrated effect of fatty liver disease-related genetic variants. Clin Gastroenterol Hepatol. 2022; 20(4): e855-e875. Liu Z#, Lin C#, Suo C#, et al. Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers. Metabolism. 2022; 127:154955. Liu Z, Suo C, Fan H, et al. Dissecting causal relationships between nonalcoholic fatty liver disease proxied by chronically elevated alanine transaminase levels and 34 extrahepatic diseases. Metabolism. 2022; 135:155270. Liu Z#, Song C#, Suo C, et al. Alcohol consumption and hepatocellular carcinoma: novel insights from prospective cohort study and nonlinear Mendelian randomization analysis. BMC Med. 2022; 20:413. Liu Z#, Lin C#, Mao X#, et al. Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people. Gut. 2023, 72(12):2354-2363.

推荐链接
down
wechat
bug